Beijing Aosaikang Pharmaceutical Co., Ltd. (SHE:002755)

Market Cap	11.93B -25.3%
Revenue (ttm)	1.75B -4.7%
Net Income	266.34M +45.2%
EPS	0.28 +38.3%
Shares Out	928.16M
PE Ratio	45.98
Forward PE	n/a
Dividend	0.12 (0.95%)
Ex-Dividend Date	n/a

Volume	8,217,550
Open	13.15
Previous Close	12.66
Day's Range	12.42 - 13.15
52-Week Range	12.49 - 29.00
Beta	0.13
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About SHE:002755

Beijing Aosaikang Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of active pharmaceutical ingredients and formulations in China. It also offers digestive health products, which include pump inhibitors suitable for various digestive tract-related diseases, such as peptic ulcers, reflux esophagitis, and upper gastrointestinal bleeding; and anti-tumor products, including the treatment of non-small cell lung cancer, colorectal cancer, and breast cancer, encompassing targeted therapy, chemotherapy, endocrine ther...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1996
• Employees: 799
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002755

Financial Performance

In 2025, SHE:002755's revenue was 1.78 billion, an increase of 0.08% compared to the previous year's 1.78 billion. Earnings were 236.60 million, an increase of 47.60%.